https://www.selleckchem.com/pr....oducts/Tanshinone-I.
Skin cancer poses a significant burden to patients in GCC countries and improved patient education will enhance population health.OBJECTIVE Poly(ADP-ribosyl) polymerases (PARPs) are nuclear enzymes with roles in DNA damage recognition and repair. PARP1 inhibition enhances the effects of DNA-damaging agents like doxorubicin. We sought to determine the recommended phase two dose (RP2D) of veliparib with pegylated liposomal doxorubicin (PLD) in breast and recurrent gynecologic cancer patients. METHODS Veliparib and PLD were administer
Like
Comment
Share
